Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer
AUAUniversity31 Mars 2017

Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer

The goal of this knowledge-based activity is to improve clinicians' understanding of current immunotherapeutic agents for the treatment of bladder cancer and to increase their ability to improve patient outcomes and the management of adverse events. Educational grants provided by the following corportations: AstraZeneca, Bristol-Myers Squibb, Genentech, Merck

Avsnitt(426)

AUA2018 Residents Forum - The Evolving Practice Of Urology

AUA2018 Residents Forum - The Evolving Practice Of Urology

AUA2018 Residents Forum - The Evolving Practice Of Urology by American Urological Association

15 Nov 201838min

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career by American Urological Association

13 Nov 201843min

Immuno-Oncology: A Focus on Kidney Cancer

Immuno-Oncology: A Focus on Kidney Cancer

Immuno-Oncology: A Focus on Kidney Cancer is the third in the 4-part series. Topics will include "Review of Treatment Options for Systemic Disease", "Cytoeduction Debate" and "Impact of Immunotherapy ...

8 Nov 201847min

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer: Present and Future is the fourth and final in a 4-part series. Topics will include "Role of Chemotherapy and Performance Sta...

1 Nov 201844min

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

29 Okt 201837min

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer is the second in the 4-part series. Topics will include "non muscle invasive disease" and "muscle invasive disease" as well as "clinical trial evidence" and ...

24 Okt 201854min

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

Speakers: Christopher M. Gonzalez, MD, MBA James M. Dupree, MD, MPH

22 Okt 201817min

Incorporating New IO Therapies - Managing Patient Side Effects

Incorporating New IO Therapies - Managing Patient Side Effects

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

19 Okt 201830min

Populärt inom Utbildning

rss-bara-en-till-om-missbruk-medberoende-2
historiepodden-se
det-skaver
alska-oss
nu-blir-det-historia
sektledare
harrisons-dramatiska-historia
not-fanny-anymore
roda-vita-rosen
johannes-hansen-podcast
allt-du-velat-veta
rss-viktmedicinpodden
sa-in-i-sjalen
i-vantan-pa-katastrofen
rss-sjalsligt-avkladd
rss-basta-livet
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-om-vi-ska-vara-arliga
rss-max-tant-med-max-villman
vi-gar-till-historien